“…20,21 Bulk organogels from LMWGs can be easily downsized to aqueous colloidal dispersions of gelled-oil nanoparticles (GNPs) via a two-step process in which emulsified oil droplets are typically generated via a hot emulsification process followed by cooling. 24−27 Although GNPs have exhibited the potential for the encapsulation, protection, and delivery of a variety of bioactives with low water solubility (i.e., nile red and efavirenz, 28 rose bengal and hypericine, 29 rhodamine 123, 30 curcumin, 31,32 curcuminaldehyde, 33 sunscreen, 34 indomethacin and ketoconazole, 35 metallophthalocyanine, 36 flurbiprofen, 37 β-carotene, 38 coumarin, 39 paclitaxel, 40,41 and doxorubicin 42 ), they are still relatively seldom used. The commercially available 12-hydroxystearic acid (HSA) is the most commonly used LMWG for GNPs, 25,28,[34][35][36][37]40,41 and thus the development of new custom LWMGs offers the opportunity to form gels with a wider variety of organic liquids 43,44 as well as introduce other interesting properties to trigger different types of stimuliresponsive systems that could enable tunable release characteristics.…”